Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History GERN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics GERN

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Geron Corporation

GERN
Current price
1.32 USD -0.06 USD (-4.35%)
Last closed 1.38 USD
ISIN US3741631036
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 878 946 880 USD
Yield for 12 month -73.06 %
1Y
3Y
5Y
10Y
15Y
GERN
21.11.2021 - 28.11.2021

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California. Address: 919 East Hillsdale Boulevard, Foster City, CA, United States, 94404

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.69 USD

P/E Ratio

Dividend Yield

Financials GERN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures GERN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+76 994 000 USD

Last Year

+237 000 USD

Current Quarter

+39 603 000 USD

Last Quarter

+47 537 000 USD

Current Year

+75 738 000 USD

Last Year

-123 503 000 USD

Current Quarter

+38 397 000 USD

Last Quarter

+46 754 000 USD
EBITDA -133 736 000 USD
Operating Margin TTM -42.18 %
Price to Earnings
Return On Assets TTM -16.07 %
PEG Ratio -2.38
Return On Equity TTM -45.35 %
Wall Street Target Price 3.69 USD
Revenue TTM 116 293 000 USD
Book Value 0.42 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 12 927.30 %
Dividend Yield
Gross Profit TTM 9 379 000 USD
Earnings per share -0.21 USD
Diluted Eps TTM -0.21 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -119.54 %

Stock Valuation GERN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 5.52
Price Sales TTM 7.56
Enterprise Value EBITDA -9.06
Price Book MRQ 3.42

Technical Indicators GERN

For 52 Weeks

1.17 USD 5.06 USD
50 Day MA 1.43 USD
Shares Short Prior Month 65 226 271
200 Day MA 2.66 USD
Short Ratio 5.75
Shares Short 62 985 757
Short Percent 10.71 %